Symposium VI
Tropical and Emerging Infections

Programme

• 14:30 – 15:05 30 Min. 5 Min.

  • Key-Note-Lecture
  • S-6-1

  Towards outbreak prediction?

  • Prof. Marion Koopmans (Rotterdam/ NL)
• 15:05 – 15:20 10 Min. 5 Min.

  • Highlight-Vortrag
  • S-6-2

  Multipathogen Antigen Test Kit (MAK-5) – distribution and frequency of viral respiratory diseases in Germany among volunteers in the VACCELERATE Registry

  • Dr. Jon Salmanton-García (Cologne/ DE)

   Tropical and Emerging Infections
• 15:20 – 15:30 8 Min. 2 Min.

  • Short Talk
  • S-6-3

  The immune system contributes to treatment efficacy of the anthelmintic benzimidazole oxfendazole

  • Prof. Dr. Marc P. Hübner (Bonn/ DE)

   Tropical and Emerging Infections
• 15:30 – 15:40 8 Min. 2 Min.

  • Short Talk
  • S-6-4

  The vaccine candidate MVA-MERS-S against Middle East Respiratory Syndrome Coronavirus: safety and immunogenicity results from a randomized-controlled Phase Ib trial

  • Dr. med. Anahita Fathi (Hamburg/ DE)

   Tropical and Emerging Infections
• 15:40 – 15:50 8 Min. 2 Min.

  • Short Talk
  • S-6-5

  A randomized controlled phase II clinical trial assessing pharmacokinetics of favipiravir for the treatment of Lassa fever

  • Dr. Mirjam Groger (Hamburg/ DE)

   Tropical and Emerging Infections
• 15:50 – 16:00 8 Min. 2 Min.

  • Short Talk
  • S-6-6

  Paving the way for the introduction of paediatric praziquantel in schistosome endemic countries: a cross-sectional study from Madagascar

  • Pia Rausche (Hamburg/ DE)

   Tropical and Emerging Infections